Vaccines

The Food and Drug Administration expanded authorization of Pfizer-BioNTech's COVID vaccine to enable kids ages 5 to 11 who were vaccinated at least five months ago to get a third shot.

The company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.

With yet another COVID-19 booster available for vulnerable populations in the U.S., many people find themselves wondering what the end game will be.

Anthony Fauci walks through what he predicts the BA.2 subvariant will do in the U.S., whether we will need boosters every four months and his advice for masking at indoor events.

People who are 50 and older and certain immunocompromised individuals may get a second Pfizer-BioNTech or Moderna COVID-19 vaccine booster four months after they received the first.

No deaths were reported in tests, and there were no signs of myocarditis, or heart inflammation, as a side effect.

If approved, this would be the second booster shot Moderna has issued for people ages 18 and up.

The White House asked for more money from Congress to keep its COVID response going. But that hasn't happened, so some things need to be wound down.

As we head into year three of the pandemic, where do things stand? And what might be ahead? KUT's Ashley Lopez tackles these questions and more.

APH says its officials will be discussing local trends, the importance of being up-to-date with COVID vaccines and changes to APH operations.